2019-08607. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info Start Printed Page 18055

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved By OMB

    Title of collectionOMB control No.Date approval expires
    Survey of Current Manufacturing Practices for the Cosmetic Industry0910-08673/31/2020
    Environmental Impact Considerations0910-03222/28/2022
    Generic Clearance for Quantitative Testing of the Development of Food and Drug Administration0910-08652/28/2022
    Investigational New Drug Regulations0910-00143/31/2022
    Prescription Drug User Fee Program0910-02973/31/2022
    Food Additives, Food Contact Substance Notification System0910-04953/31/2022
    SPF Labeling and Testing Requirements for OTC Sunscreen Products0910-07173/31/2022
    Generic Drug User Fee Program0910-07273/31/2022
    Experimental Study of Cigarette Warnings0910-08663/31/2022
    Assessment of Combination Product Review Practices0910-08683/31/2022
    Start Signature

    Dated: April 24, 2019.

    Lowell J. Schiller,

    Principal Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2019-08607 Filed 4-26-19; 8:45 am]

    BILLING CODE 4164-01-P